BRCA2 and breast carcinoma: When we analyzed the copy number variations of RNH1 in patient samples from 2 breast cancer TCGA data sets (TCGA, Cell and Firehose Legacy), we found the copy number amplification was significantly higher in BRCA2-low; MLH1-low human breast cancer samples compared with unaltered controls (Figure 4C).